{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:09:02Z","timestamp":1784549342955,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.urolonc.2026.110993","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:59:35Z","timestamp":1770425975000},"page":"110993","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patient awareness and perspectives regarding the value of focal therapy for localized prostate cancer: A cross-sectional study"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8146-1620","authenticated-orcid":false,"given":"Abdul-Qahar K.","family":"Yasinzai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amica","family":"Lertkitcharoenpo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael A.","family":"Bourricaudy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane J.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"Stringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Michael","family":"DiBianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason P.","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padraic","family":"O\u2019Malley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L.","family":"Crispen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ming","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarik","family":"Benidir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2026.110993_bib0001","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA: Cancer J Clin"},{"key":"10.1016\/j.urolonc.2026.110993_bib0002","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate Cancer-2024 update. Part I: screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2026.110993_bib0003","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.euo.2023.12.007","article-title":"Patient-reported side effects 1 year after radical prostatectomy or radiotherapy for prostate cancer: a register-based nationwide study","volume":"7","author":"Corsini","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.urolonc.2026.110993_bib0004","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1001\/jama.2017.1652","article-title":"Association between choice of radical prostatectomy, external beam radiotherapy, brachytherapy, or active surveillance and patient-reported quality of life among men with localized prostate cancer","volume":"317","author":"Chen","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.urolonc.2026.110993_bib0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.eururo.2021.08.005","article-title":"An updated systematic review on focal therapy in localized prostate cancer: what has changed over the past 5 years?","volume":"81","author":"Hopstaken","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2026.110993_bib0006","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/s41391-021-00369-6","article-title":"Conventional radical versus focal treatment for localised prostate cancer: a propensity score weighted comparison of 6-year tumour control","volume":"24","author":"van Son","year":"2021","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urolonc.2026.110993_bib0007","first-page":"203","article-title":"Focal therapy: a new paradigm for the treatment of prostate cancer","volume":"11","author":"Tareen","year":"2009","journal-title":"Rev Urol"},{"key":"10.1016\/j.urolonc.2026.110993_bib0008","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1089\/end.2010.0006","article-title":"Candidate selection for prostate cancer focal therapy","volume":"24","author":"Taneja","year":"2010","journal-title":"J Endourol"},{"key":"10.1016\/j.urolonc.2026.110993_bib0009","article-title":"Identifying the best candidate for focal therapy: a comprehensive review","author":"Ghoreifi","year":"2024","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urolonc.2026.110993_bib0010","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/pon.5362","article-title":"Decision regret in men living with and beyond nonmetastatic prostate cancer in the United Kingdom: a population-based patient-reported outcome study","volume":"29","author":"Wilding","year":"2020","journal-title":"Psychooncology"},{"key":"10.1016\/j.urolonc.2026.110993_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2023.102492","article-title":"\"Shared decision-making\" for prostate cancer screening: is it a marker of quality preventative healthcare?","volume":"88","author":"Golijanin","year":"2024","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.urolonc.2026.110993_bib0012","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.euo.2023.02.005","article-title":"Decision regret in patients with localised prostate cancer: a systematic review and meta-analysis","volume":"6","author":"Fanshawe","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.urolonc.2026.110993_bib0013","doi-asserted-by":"crossref","unstructured":"Green BL, Small BJ, Damonte J, et al. Treatment Decision Support for Men with Prostate Cancer and Their Caregivers [Internet]. Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2019. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK599587\/. https:\/\/doi.org\/10.25302\/1.2019.CE.12115285","DOI":"10.25302\/1.2019.CE.12115285"},{"key":"10.1016\/j.urolonc.2026.110993_bib0014","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0090-4295(03)00778-7","article-title":"Impact of patient educational level on treatment for patients with prostate cancer: data from CaPSURE","volume":"62","author":"Kane","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2026.110993_bib0015","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1177\/1557988318784838","article-title":"Exploring racial differences surrounding prostate cancer screening: beliefs and attitudes in community dwelling men attending an urban men's health event","volume":"12","author":"Hewitt","year":"2018","journal-title":"Am J Mens Health"},{"key":"10.1016\/j.urolonc.2026.110993_bib0016","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkad032","article-title":"Income level and treatment selection in prostate cancer: analysis of a North Carolina population-based cohort","volume":"7","author":"Rock","year":"2023","journal-title":"JNCI Cancer Spectr"},{"key":"10.1016\/j.urolonc.2026.110993_bib0017","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41585-019-0258-3","article-title":"Financial toxicity associated with treatment of localized prostate cancer","volume":"17","author":"Imber","year":"2020","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.urolonc.2026.110993_bib0018","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.urolonc.2014.04.014","article-title":"Getting back to equal: the influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancer","volume":"32","author":"Mahal","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2026.110993_bib0019","doi-asserted-by":"crossref","first-page":"18258","DOI":"10.1002\/cam4.6419","article-title":"Disparities in time to prostate cancer treatment initiation before and after the Affordable Care Act","volume":"12","author":"Janopaul-Naylor","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.urolonc.2026.110993_bib0020","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/COC.0000000000000423","article-title":"Impact of health insurance status on prostate cancer treatment modality selection in the United States","volume":"41","author":"Bledsoe","year":"2018","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.urolonc.2026.110993_bib0021","first-page":"1","article-title":"Health disparities in prostate cancer and approaches to advance equitable care","volume":"42","author":"Washington","year":"2022","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.urolonc.2026.110993_bib0022","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.45906","article-title":"Racial and ethnic disparities in use of novel hormonal therapy agents in patients with prostate cancer","volume":"6","author":"Ma","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.urolonc.2026.110993_bib0023","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/0272989X14558424","article-title":"Decision-making processes among prostate cancer survivors with rising PSA levels: results from a qualitative analysis","volume":"35","author":"Shen","year":"2015","journal-title":"Med Decis Making"},{"key":"10.1016\/j.urolonc.2026.110993_bib0024","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/jnci\/djx218","article-title":"Prostate cancer patient characteristics associated with a strong preference to preserve sexual function and receipt of active surveillance","volume":"110","author":"Broughman","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2026.110993_bib0025","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/PPO.0b013e31819764cc","article-title":"Sexual side effects and prostate cancer treatment decisions: patient information needs and preferences","volume":"15","author":"Knight","year":"2009","journal-title":"Cancer J"},{"key":"10.1016\/j.urolonc.2026.110993_bib0026","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/JU.0000000000000754","article-title":"Evaluating the trade-offs men with localized prostate cancer make between the risks and benefits of treatments: the COMPARE Study","volume":"204","author":"Watson","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2026.110993_bib0027","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.euo.2024.04.016","article-title":"Influential factors impacting treatment decision-making and decision regret in patients with localized or locally advanced prostate cancer: a systematic literature review","volume":"7","author":"Gartrell","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.urolonc.2026.110993_bib0028","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/bju.15955","article-title":"Treatment decision regret in long-term survivors after radical prostatectomy: a longitudinal study","volume":"131","author":"Meissner","year":"2023","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2026.110993_bib0029","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s40271-017-0255-7","article-title":"Does patient preference measurement in decision aids improve decisional conflict? A randomized trial in men with prostate cancer","volume":"10","author":"Shirk","year":"2017","journal-title":"Patient"},{"key":"10.1016\/j.urolonc.2026.110993_bib0030","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/MLR.0000000000000155","article-title":"Perceptions of active surveillance and treatment recommendations for low-risk prostate cancer: results from a national survey of radiation oncologists and Urologists","volume":"52","author":"Kim","year":"2014","journal-title":"Med Care"},{"key":"10.1016\/j.urolonc.2026.110993_bib0031","doi-asserted-by":"crossref","first-page":"240.e13","DOI":"10.1016\/j.urolonc.2018.01.011","article-title":"Understanding how prostate cancer patients value the current treatment options for metastatic castration resistant prostate cancer","volume":"36","author":"Benidir","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2026.110993_bib0032","article-title":"Patient perceptions and preferences of minimally invasive treatment modalities in varicose veins: a cross-sectional survey","volume":"11","author":"Li","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.urolonc.2026.110993_bib0033","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.6026\/9732063002001641","article-title":"Patient awareness and attitudes towards minimally invasive surgery","volume":"20","author":"Kibria","year":"2024","journal-title":"Bioinformation"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926000037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926000037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:51:50Z","timestamp":1784548310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143926000037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1078143926000037"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.110993","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient awareness and perspectives regarding the value of focal therapy for localized prostate cancer: A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.110993","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110993"}}